Business · 1 sources covering this

Cipla Arm Receives One USFDA Observation at New York Facility

Cipla's wholly owned subsidiary, InvaGen Pharmaceuticals, received one Form 483 observation after a routine USFDA inspection at its New York manufacturing facility

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·3h ago
Cipla Arm Receives One USFDA Observation at New York Facility
Cipla's wholly owned subsidiary, InvaGen Pharmaceuticals, received one Form 483 observation after a routine USFDA inspection at its New York manufacturing facility
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/2b78969981b1a5aa429ba82333f78ba09019c414"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Cipla Arm Receives One USFDA Observation at New York Facility"></iframe>

Cipla Arm Receives One USFDA Observation at New York Facility

How 1 sources are covering this

Cipla Arm Receives One USFDA Observation at New York Facility

More from Business

Bitcoin rebounds to $64K after AI-led selloff triggers crypto rout. Here's what experts say

Wangchuk continues hunger strike: wife Gitanjali

Vizhinjam port to begin EXIM ops from August

Vikram-1 rocket successfully places tech payloads, postcards from astronauts, PM Modi into orbit

Reader

Trust & legal

Across the network